UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimal treatment for recurrent/metastatic head and neck cancer

Annals of oncology, 2010-10, Vol.21 (suppl-7), p.vii252-vii261

2010

Volltextzugriff (PDF)

The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck

Annals of oncology, 2014-11, Vol.25 (11), p.2101-2115

2014

Volltextzugriff (PDF)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions

Annals of oncology, 2018-05, Vol.29 (5), p.1130-1140

2018

Volltextzugriff (PDF)

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Annals of oncology, 2014-04, Vol.25 (4), p.801-807

2014

Volltextzugriff (PDF)

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

European journal of cancer (1990), 2008-04, Vol.44 (6), p.808-818

2008

Volltextzugriff (PDF)

Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor

Medicinal research reviews, 2016-07, Vol.36 (4), p.749-786

2016

Volltextzugriff (PDF)

SP-055: For the motion

Radiotherapy and oncology, 2015-02, Vol.114, p.30-30

Vermorken, J

2015

Volltextzugriff (PDF)

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Annals of oncology, 2019-01, Vol.30 (1), p.68-75

2019

Volltextzugriff (PDF)

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Annals of oncology, 2011-05, Vol.22 (5), p.1078-1087

2011

Volltextzugriff (PDF)

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

JNCI : Journal of the National Cancer Institute, 2009-02, Vol.101 (3), p.142-152

2009

Volltextzugriff (PDF)

Letter: does Helicobacter pylori infection limit the health effects of the Mediterranean diet?

Alimentary pharmacology & therapeutics, 2020-09, Vol.52 (5), p.935-936

2020

Volltextzugriff (PDF)

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Annals of oncology, 2014-03, Vol.25 (3), p.742-746

2014

Volltextzugriff (PDF)

Can niacin supplementation prevent congenital malformations associated with maternal use of proton pump inhibitors?

European journal of nutrition, 2023-03, Vol.62 (2), p.1051-1053

2023

Volltextzugriff (PDF)

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

Annals of oncology, 2008-01, Vol.19 (1), p.142-149

2008

Volltextzugriff (PDF)

SP-012: What is the Role of Induction Chemotherapy in Locally Advanced H&N Cancer in 2013?

Radiotherapy and oncology, 2013-02, Vol.106, p.S4-S4

Vermorken, J

2013

Volltextzugriff (PDF)

SP-006 - SP-007: Extreme (PF+/-Cetuximab) and Spectrum (PF+/- Panitumumab): HPV Status and Outcome

Radiotherapy and oncology, 2013-02, Vol.106, p.S2-S3

Vermorken, J

2013

Volltextzugriff (PDF)

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2010-10, Vol.21 (10), p.1967-1973

2010

Volltextzugriff (PDF)

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Annals of oncology, 2017-10, Vol.28 (10), p.2526-2532

2017

Volltextzugriff (PDF)

Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign

Annals of oncology, 2014-11, Vol.25 (11), p.2115-2124

2014

Volltextzugriff (PDF)

Phase 3 randomised study of canfosfamide (Telcyta® , TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2324-2332

2009

Volltextzugriff (PDF)

Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?

Annals of oncology, 2006-08, Vol.17 (8), p.1197-1204

2006

Volltextzugriff (PDF)

Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome

Annals of oncology, 2009-02, Vol.20 (2), p.331-336

2009

Volltextzugriff (PDF)

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy

PloS one, 2012-10, Vol.7 (10), p.e40388

2012

Volltextzugriff (PDF)

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Breast cancer research and treatment, 2022-07, Vol.194 (2), p.265-278

2022

Volltextzugriff (PDF)

Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents

Journal of nanoscience and nanotechnology, 2016-06, Vol.16 (6), p.6258-6264

2016

Volltextzugriff (PDF)

1 – 25 von 802

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(712)
Mit Volltextzugriff
(696)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(461)
Humans
(460)
Life Sciences & Biomedicine
(452)
Oncology
(314)
Female
(302)
Biological And Medical Sciences
(270)
Medical Sciences
(260)
Middle Aged
(217)
Pharmacology. Drug Treatments
(194)
Adult
(188)
Aged
(187)
Antineoplastic Agents
(153)
Male
(149)
Chemotherapy
(136)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(99)
Tumors
(99)
Ovarian Neoplasms - Drug Therapy
(76)
Animals
(73)
Treatment Outcome
(68)
Cisplatin - Administration & Dosage
(58)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Optimal treatment for recurrent/metastatic head and neck cancer

The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor

SP-055: For the motion

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

Letter: does Helicobacter pylori infection limit the health effects of the Mediterranean diet?

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Can niacin supplementation prevent congenital malformations associated with maternal use of proton pump inhibitors?

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

SP-012: What is the Role of Induction Chemotherapy in Locally Advanced H&N Cancer in 2013?

SP-006 - SP-007: Extreme (PF+/-Cetuximab) and Spectrum (PF+/- Panitumumab): HPV Status and Outcome

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign

Phase 3 randomised study of canfosfamide (Telcyta® , TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?

Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents

Suchergebnisse filtern